Declaration: IAS Aging Matters Magazine is intended for IAS private members (and therefore is not intended for the public). It focuses on the latest international nutritional, hormonal and drug therapies to help combat the signs of aging. If you continue to use this site we will assume that you have read and agreed to the full declaration.


Read the full declaration
Mar 19th, 2024 DOWNLOAD OUR LATEST AGING MATTERS MAGAZINE FOR FREE
Close up of a woman's grey/green eye and ginger hair

Can-C™ the non-surgical cataract treatment

April 27th, 2017

It’s good news… Eye surgery is no longer the only option available if you suffer from conditions such as cataracts, or blurred vision.

Can-C™ eye-drops give the opportunity to take control of various eye conditions. Helping to turn back the hands of time on what was once thought of as just being part and parcel of growing old, but can now in many cases be treated effectively, without the need for any invasive procedures at all.

Thanks to remarkable Russian research, Can-C™ eye-drops offer a genuine alternative to surgery. Now, cataracts can be treated simply by the daily use of eye-drops. Specifically designed for the treatment of senile cataracts and using a unique, patented formula containing the active and natural ingredient N-acetylcarnosine. Can-C™ eye-drops gently but effectively can slow, halt and even reverse the progress of cataracts. And the results are evident incredibly quickly. Even after just 1 month of treatment, the effects of Can-C™ eye-drops are clearly visible – breaking down the impaired proteins in the crystalline of the lens that cause the cataracts.

Cataract is the leading cause of blindness and accounts for about 42% of all such cases worldwide. More than 17 million people around the world are blind because of cataract and an alarmingly, 28,000 new cases are reported every day. Excessive oxidation (free radical damage) is the key cause of cataracts and other degenerative, age-related eye conditions such as macular degeneration and glaucoma. Free radicals are toxic by-products of your everyday metabolism.

With aging, the production of these free radicals increases, whereas the body defences against them become less effective. Free radicals destroy proteins, enzymes and DNA causing chronic damage to tissues. A related process known as glycation is also strongly implicated; this process which conveniently abbreviates to AGE (advanced glycated end-products) is one where oxygen and glucose impair protein by cross-linking them.

Can-C™ is the original N-acetylcarnosine (NAC) eye-drop formula. The drops have been commercially sold since 2001 and in that time has helped many thousands of people treat their senile cataracts without the need for surgery. In fact, it is estimated that there have now been more than 50,000 documented patient cases of Can-C™ use.

With Can-C™, you get to keep your natural lens

Vision may be the most precious of our five senses. Yet most of us take it for granted until it begins to deteriorate with age. Many thousands of patients using the eye-drops have noticed improvements of their vision, ranging from mild improvement to complete resolution of the condition. According to the manufacturers of Can-C™ lubricant eye-drops, with over half a million bottles sold worldwide. This means that many people have retained their natural lens and not needed to have it replaced by a plastic one. It should be obvious that a plastic lens does not have the optic accommodation and capacity of a natural one.

Vision is precious. Pictures are worth a thousand words

So many times we hear people say, “My eyes aren’t what they used to be.” The simple fact is… they most probably aren’t. But that’s life, we get older and our bodies change. However, you don’t have to sit back and give up hope for improved vision.

The cataract eye-drop treatment is a proven and scientific one and based on clinical experience

If you are frustrated with your eyesight, ask yourself these questions:

  • Are my eyes sensitive to light; or do I get cloudiness in parts of my vision?
  • Which problem do I deal with first? My difficulty driving at night, the overwhelming glare or my increased near sightedness?
  • When did this start happening to me? Is it stable or getting worse?
  • Why is this happening to me?

You could be the fittest person in the neighbourhood but your eyes may tell a different story.

Everyone has their story. As we talk to customers all the time, they ask questions and we help to provide the answers.

Some examples:

  • Can Can-C be taken in conjunction with other common eye supplements such as lutein and zeaxanthin / astaxanthin?

We do not recommend that the Can-C™ eye-drops are combined with lutein (unless a patient has a cataract associated with a retinal disorder), this is because lutein appears to interfere with the same receptor sites as NAC and may lower the efficacy of the eye-drops. You should stop taking lutein for at least the first 6 months but after this period they may be started again. This is because Can-C™ does the majority of its restorative work in that period and thereafter it is maintenance, thus a reduced efficacy is not so essential. The same is true for zeaxanthin; however we are not aware of contraindications with astaxanthin.

  • How long has Can-C™ been available?

Can-C has been sold since 2001 and in that time has helped thousands of people treat their senile cataracts without surgery.

  • Are there any problems using Can-C™ concurrently with other eye-drops for glaucoma pressure control? Would you recommend use of both?

To date, there have been no noted contraindications or side effects noted with the use of other eye-drops combined with Can-C™, but naturally, as there are so many versions, not all eye-drops have been tested along with the same. Dr. Mark Babizhayev (the inventor of the technology) has stated that beta blocker eye-drops used for glaucoma may actually have additional benefit when combined with Can-C™ to help further reduce the intraocular pressure.

Look to your future with clearer vision

The statistics in the human trials for Can-C™ show that N-acetylcarnosine eye-drops applied for 6-months twice daily into the eye, in patients, all suffering from senile cataract, had the following results:

  1. 88.9% had an improvement in glare sensitivity.
  2. 41.5% had an improvement of the transmissivity of the lens.
  3. 90% had an improvement in visual acuity.

Note: You can also maximise the benefit of using Can-C™ eye drops by taking Can-C™ Plus capsules. They are especially recommended in difficult cases, or for ripe cataracts (cataracts that have existed for a long time). So those who have very dense cataract and severely diminished vision to start with should combine the capsules with the eye-drops from day one.

The Can-C™ products can assist with lots of other eye conditions, such as:

  • Dry eye syndrome
  • Contact lens comfort (both as a lubricant and also because they block the painful accumulation of lactic acid which is caused by the contact lens rubbing onto the eye).
  • Corneal disorders
  • Computer vision syndrome
  • Eye strain
  • Ocular inflammation
  • Blurred vision
  • Presbyopia
  • Retinal issues
  • Vitreous opacities and lesions
  • Complications of diabetes mellitus and other systemic diseases
  • Open-angle primary glaucoma

Can-C™ is a non-surgical cataract treatment. No risk, no large medical bills and no time off work! The reasons you should look after your eyes are many, especially when you consider the potential risks involved with surgery.

Complications of short term cataract surgery

Cataract surgery may be the most performed surgical procedure in the world, but it is not without its problems and complications – for example, 24 hours after surgery the following can occur:

  • Bleeding inside the eye, where the actual surgery is being performed. This can be inside the back of the eye or inside the front.
  • A black eye (bruise) around the eye – this is often caused when you have an injection during the operation
  • Leaks around the wound or incision where the corneal incision may not seal properly.
  • An inner eye infection (endophthalmitis) – rare but does happen
  • Posterior capsule rupture, which is where the opacified lens material (the “cloudy” bit) is “chopped up) to suction it from the eye. The posterior lens capsule can rupture or tear during this process.
  • The retina can detach, which is a greater risk for people who are extremely near sighted
  • Secondary glaucoma, which is very unusual in general but can be brought on if there is any other bleeding or inflammation.
  • Significant astigmatism, if it was necessary to use stiches or sutures during the durgery because the corneal incision didn’t seal properly. This can distort the cornea and induce astigmatism

Long term complications of cataract surgery*

*Long term cataract surgery problems and complications are those that we will define as occurring from one week to as long as six months after cataract surgery.

  • Dislocated/decentred intraocular lens implant (IOL) – the artificial lens implant (IOL) can move slightly, which is classed as dislocated or displaced
  • Cystoid macular edema – this can happen during the first 3 months after surgery, where the macula is prone to microscopic swelling
  • Secondary/after cataract – this is the most common problem after cataract surgery and is where a secondary cataract forms – it happens in up to 30% of all surgical cases. It happens when the posterior lens capsule opacifies. The vision will become gradually blurry over time, and sufferers will need a YAG laser capsulotomy to create a small hole in the cloudy membrane,

Knowledge is power

“Life begins at 40 – but so do fallen arches, rheumatism, faulty eyesight, and the tendency to tell a story to the same person, three or four times.” (Helen Rowland)

Additional reading on this topic

Dr. Mark Babizhayev is one of the principal Russian researchers behind the development and use of N-acetylcarnosine or NAC eye-drops. In his interview, he discusses with Phil from International Anti-Aging Systems (IAS) some of the results of his research.

Read the whole interview here: www.antiaging-systems.com/articles/172-interview-with-mark-babizhayev-phd-about-the-development-of-can-c-eye-drops

Login

Lost your password?